Exelixis Inc 2024 SR
The report highlights Exelixis' progress in oncology innovation and ESG initiatives for the period ending June 30, 2024. Key achievements include enhancing clinical trial diversity through the 'Clinical Trial Inclusiveness Initiative' and supporting over 1,700 nonprofit organizations. The company achieved a 1:1 gender pay ratio and expanded its employee resource groups to eight. Environmentally, Exelixis implemented an energy dashboard for its LEED Gold-certified Alameda headquarters and utilized 100% clean electricity. Governance was strengthened with 91% board independence and 36% female board representation.
Company: Exelixis Inc
Sector: Health Care
Country: United States
Year: 2024
Type: SR
Pages: 70
Exelixis Inc
The report highlights Exelixis' progress in oncology innovation and ESG initiatives for the period ending June 30, 2024. Key achievements include enhancing clinical trial diversity through the 'Clinical Trial Inclusiveness Initiative' and supporting over 1,700 nonprofit organizations. The company achieved a 1:1 gender pay ratio and expanded its employee resource groups to eight. Environmentally, Exelixis implemented an energy dashboard for its LEED Gold-certified Alameda headquarters and utilized 100% clean electricity. Governance was strengthened with 91% board independence and 36% female board representation.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jul 1, 2023 - Jun 30, 2024
Fiscal Year
2024
Published
Oct 1, 2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Employees